Draganfly Inc. is facing noncompliance with the Nasdaq Listing Rule 5550(b)(1) due to a stockholders' equity deficiency, potentially leading to delisting from the Nasdaq Capital Market.
The company reported a stockholders' equity of C$407,716 (equivalent to $308,897) in its Form 20-F, falling short of the required minimum of $2,500,000 for continued listing on Nasdaq.
A hearing before an independent Nasdaq Hearings Panel is scheduled for May 21, 2024, to address the bid price deficiency and the Stockholders' Equity Rule deficiency. The outcome of the hearing will determine the company's continued listing on Nasdaq.
The Panel has the discretion to grant an extension period for the Stockholders' Equity Rule deficiency, potentially until October 2, 2024. However, there is no guarantee that the Panel will approve the company's compliance plan or that Draganfly will regain compliance with listing requirements.